Tinea Pedis — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for tinea pedis. 39 active patents protecting 4 drugs from 4+ originators. First major cliff: 2032. Daily refresh.

4
Approved drugs
39
Active US patents
57/100
Avg vulnerability
—
Annual revenue covered

Originators in Tinea Pedis

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Merck & Co. 20 patents Generic (originally Merck/Upjohn) 14 patents Bausch Health 4 patents Bayer AG 1 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating tinea pedis. Each bar = one year. Y-axis scaled to peak year (10 patents).

1
27
7
30
10
31
4
32
7
33
5
34
2
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Diprolene
BETAMETHASONE DIPROPIONATE
 Merck & Co. 20 62 — 2027-09-27
Cortef
hydrocortisone
 Generic (originally Merck/Upjohn) 14 64 — 2032-11-19
Luzu
LULICONAZOLE
 Bausch Health 4 28 — 2033-09-06
Lotrimin
clotrimazole
 Bayer AG 1 75 — 2042-05-26

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12440499 Diprolene method of use 75 2039-03-18
12246006 Lotrimin method of use 75 2042-05-26
11904046 Cortef method of use 75 2043-02-23
12133914 Cortef method of use 75 2043-02-23
9877974 Diprolene method of use 68 2030-08-31
9364485 Diprolene method of use 68 2030-08-31
9655907 Diprolene method of use 68 2030-08-31
9433630 Diprolene method of use 68 2030-08-31
9775851 Diprolene method of use 68 2030-08-31
10179137 Diprolene method of use 68 2030-08-31

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
9453006 Luzu composition of matter 4 2033-09-06
9199977 Luzu composition of matter 4 2033-09-06
8980931 Luzu formulation 42 2034-04-28
10682364 Diprolene formulation 48 2031-06-10
10716799 Diprolene formulation 48 2031-06-10
10617698 Diprolene formulation 48 2031-06-10
9566286 Diprolene formulation 48 2031-06-10
10130640 Diprolene formulation 48 2031-06-10
11696919 Diprolene formulation 50 2039-03-18
10265265 Diprolene formulation 55 2027-09-27

Related